Blue Crest Capital Management LTD Danaher Corp Transaction History

Blue Crest Capital Management LTD

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$185.1 - $233.13 $290,236 - $365,547	1,568 Added 33.48%	6,251 $1.45 Million
Q3 2023 Nov 14, 2023	BUY	$233.08 - $265.59 $1.09 Million - $1.24 Million	4,683 New	4,683 $1.16 Million
Q4 2022 Feb 14, 2023	SELL	$241.42 - $282.29 $10.9 Million - $12.7 Million	-45,163 Reduced 69.18%	20,121 $5.34 Million
Q3 2022 Nov 14, 2022	BUY	$247.06 - $1507.4 $12.7 Million - $77.7 Million	51,547 Added 375.24%	65,284 $16.9 Million
Q2 2022 Aug 15, 2022	SELL	$237.11 - $299.66 $22.5 Million - $28.4 Million	-94,907 Reduced 87.36%	13,737 $3.48 Million
Q1 2022 May 16, 2022	BUY	$257.27 - $315.76 $6.15 Million - $7.55 Million	23,924 Added 28.24%	108,644 $31.9 Million
Q4 2021 Feb 14, 2022	BUY	$292.08 - $329.01 $10.6 Million - $11.9 Million	36,289 Added 74.93%	84,720 $27.9 Million
Q3 2021 Nov 15, 2021	BUY	$272.21 - $332.43 $13.2 Million - $16.1 Million	48,431 New	48,431 $14.7 Million
Q1 2021 May 17, 2021	SELL	$212.38 - $245.9 $6.89 Million - $7.98 Million	-32,452 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$212.5 - $245.46 $6.9 Million - $7.97 Million	32,452 New	32,452 $7.21 Million
Q3 2020 Nov 16, 2020	SELL	$177.16 - $215.33 $671,790 - $816,531	-3,792 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$128.7 - $176.83 $488,030 - $670,539	3,792 New	3,792 $671,000
Q4 2019 Feb 14, 2020	SELL	$133.47 - $153.48 $6.49 Million - $7.46 Million	-48,596 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$135.4 - $146.47 $6.58 Million - $7.12 Million	48,596 New	48,596 $7.02 Million

2,430

563M

3.94M

4.11M

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $177B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

Get notified when there are updates to the investment portfolio of Blue Crest Capital Management LTD, based on Form 13F filings with the SEC.

Stay updated on Blue Crest Capital Management LTD with notifications on news.